Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO)-Reference-Cited by-同舟云学术

Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO)

Published:2019-09-05 Issue:2 Volume:39 Page:471-477
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Min Hong Ki,Lee Jennifer,Ju Ji Hyeon,Park Sung-Hwan,Kwok Seung-Ki

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04767-z.pdf

Reference15 articles.

1. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Sodergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76:17–28. https://doi.org/10.1136/annrheumdis-2016-209775

2. Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindstrom U, Askling J, Jacobsson LTH (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19:102. https://doi.org/10.1186/s13075-017-1315-z

3. Di Minno MN, Ambrosino P, Peluso R, Di Minno A, Lupoli R, Dentali F (2014) Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-alpha blockers: a meta-analysis of prospective studies. Ann Med 46:73–83. https://doi.org/10.3109/07853890.2013.874661

4. Dobiasova M, Frohlich J (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 34:583–588

5. Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA, Yavuz F, Arslan S, Kucuk A (2018) Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS. Clin Rheumatol 37:1273–1280. https://doi.org/10.1007/s10067-018-4027-0

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis;Journal of Rheumatic Diseases;2023-11-09

2. Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile;Frontiers in Immunology;2023-07-18

3. Cardiovascular risk in axial spondyloarthritis—a systematic review;Clinical Rheumatology;2023-07-07

4. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis;Clínica e Investigación en Arteriosclerosis;2022-09

5. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis;Clínica e Investigación en Arteriosclerosis (English Edition);2022-09